Roche CEO Uncovers Hidden Mpox Cases in Europe

Roche's CEO, Thomas Schinecker, revealed that Europe likely has more mpox infection cases than reported. The company could swiftly increase its test kit production to meet demand. Schinecker made these comments during a media call following Roche's quarterly sales announcement.

Thomas Schinecker, CEO of Roche, has disclosed that Europe likely harbors more cases of mpox infection than currently reported. In a recent media call, Schinecker emphasized the group's capacity to rapidly expand its supply of test kits.

Schinecker noted, 'It seems like there are more mpox cases already in Europe, maybe not all of them are in the media yet.' This statement came after the renowned Swiss drugs and diagnostics firm detailed its quarterly sales figures.

With Roche's ability to potentially offer 10 times the current demand for test kits, the pharmaceutical giant is poised to tackle the growing health challenge in Europe.

(With inputs from agencies.)